COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
17/04/2019
Company announcement – No. 14 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, April 17, 2019 – Zealand Pharma (“Zealand”) announces that its [...]
Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Announcement no. 3/2019 17 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday by the FDA that the PMA for [...]
Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
17/04/2019
Press release April 17th, 2019 at 09.30 local time (EEST) Biohit Oyj and Difar Distribuzione s.r.l have signed an agreement for the distribution of the Acetium® lozenge in Italy. CEO Semi Korpela, Biohit Oyj: “We are [...]
QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.
17/04/2019
Press Release: 17 April 2019 QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be [...]
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer
17/04/2019
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A 2A Antagonist in Patients with Advanced Cancer First cohort of patients with advanced cancer now dosed with EOS100850 Target enrollment of 72 [...]
RESULTATS ANNUELS 2018
17/04/2019
RESULTATS ANNUELS 2018 Objectifs de rentabilité atteints avec un EBITDA à 5 M€ Poursuite du développement en biologie moléculaire (+36% à 9 M€) Structure financière solide pour des objectifs de croissance ambitieux [...]
AroCell establish a Scientific Advisory Board
17/04/2019
AroCell announces today that we have established a Scientific Advisory Board to support the company in its planned expansion for the coming years. The Scientific Advisory Board (SAB) will have the objective to support [...]
Notice of Annual General Meeting of Arocell ab (publ)
17/04/2019
Available in Swedish only Aktieägarna i AroCell AB (publ), org.nr 556596–6107 (”Bolaget”) kallas härmed till årsstämma torsdagen den 16 maj 2019, kl. 13 i lokalen Karin Boye på Virdings allé 32 B i Uppsala. [...]
Brainsway Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares
17/04/2019
JERUSALEM, Israel, April 16, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ: BWAY and TASE: BRIN) (“Brainsway”) today announced that it has priced its initial public offering of 2,500,000 American Depositary Shares (“ [...]
R1 Announces Appointment of Jill Smith to Board of Directors
16/04/2019
Charles Ditkoff Announces Decision to Retire from Board at Annual Meeting CHICAGO, April 16, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services [...]
Inspire Medical Systems, Inc. Announces the 5,000th Patient to Receive Inspire Therapy
16/04/2019
MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
WW – the new Weight Watchers – Announces NASDAQ Stock Ticker Symbol Change to WW
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that it will [...]
Equillium to Present at Solebury Trout Class of 2018 Biotech IPO Investor Day
16/04/2019
LA JOLLA, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that Bruce Steel, Equillium’s [...]
Wright Medical Group N.V. to Present at Bank of America Merrill Lynch Healthcare Conference 2019
16/04/2019
Wednesday, May 15, 2019 at 9:20 a.m. Pacific Time AMSTERDAM, The Netherlands, April 16, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the Bank of America [...]
Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
16/04/2019
Highlights the Potential for Re-dosing of AAV-based Vectors when Administered in Combination with ImmTOR (SVP-Rapamycin) WATERTOWN, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a [...]
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/04/2019
MALVERN, Pa. and SAN DIEGO, April 16, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO
16/04/2019
MENLO PARK, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the [...]
AB Science presented new preclinical data for masitinib in ALS at the 2019 Muscular Dystrophy Association Conference
16/04/2019
Paris, 16 April 2019, 8pm New preclinical data for masitinib in amyotrophic lateral sclerosis (ALS) presented at the 2019 Muscular Dystrophy Association Conference Data provides further evidence on masitinib’s mode of [...]
AB Science a présenté de nouvelles données précliniques du masitinib dans la SLA à laconférence 2019 de la Muscular Dystrophy Association
16/04/2019
Paris, 16 avril 2019, 20h De nouvelles données précliniques du masitinib dans la sclérose latérale Amyotrophique (SLA) ont été présentées à la conférence 2019 de la Muscular Dystrophy Association Ces données renforcent [...]

Pages